webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

N-(2-(2-Chloroethoxy)ethyl)-4-Formylbenzamide

  CAS No.: 1137575-49-5   Cat No.: BADC-00523 4.5  

N-(2-(2-Chloroethoxy)ethyl)-4-Formylbenzamide is an aldehyde-functionalized ADC linker optimized for bioorthogonal conjugation, offering high specificity in antibody-drug conjugate development to enhance targeted delivery and controlled payload release.

N-(2-(2-Chloroethoxy)ethyl)-4-Formylbenzamide

Structure of 1137575-49-5

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C12H14ClNO3
Molecular Weight
255.7
Shipping
Room temperature

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
4-[2-(2-Chloroethoxy)ethyl]carbamoylbenzaldehyde
IUPAC Name
N-[2-(2-chloroethoxy)ethyl]-4-formylbenzamide
Canonical SMILES
C1=CC(=CC=C1C=O)C(=O)NCCOCCCl
InChI
InChI=1S/C12H14ClNO3/c13-5-7-17-8-6-14-12(16)11-3-1-10(9-15)2-4-11/h1-4,9H,5-8H2,(H,14,16)
InChIKey
ZPJKWGXCBFJHKH-UHFFFAOYSA-N
Shipping
Room temperature

Key Applications in Medicinal Chemistry: N-(2-(2-Chloroethoxy)ethyl)-4-Formylbenzamide is primarily recognized for its potential in medicinal chemistry, particularly in the design of novel drug candidates. The compound’s structure allows it to interact with biological molecules through its chloroethoxy and formylbenzamide groups, making it a versatile scaffold for synthesizing bioactive molecules. Researchers are exploring its use in the development of selective inhibitors for various enzymes, including those involved in cancer cell proliferation and inflammation. Its ability to modify cellular processes through receptor binding and enzyme inhibition is key to its therapeutic potential.

Role in Drug Delivery Systems: Another significant application of N-(2-(2-Chloroethoxy)ethyl)-4-Formylbenzamide lies in drug delivery systems. The presence of the chloroethoxy group enhances its solubility and stability in aqueous environments, making it suitable for incorporation into formulations such as liposomes or nanoparticles. This structural feature allows for controlled release and targeted drug delivery, particularly in the treatment of diseases such as cancer or neurodegenerative disorders. By improving the pharmacokinetics and bioavailability of therapeutic agents, this compound could contribute to the development of more effective treatments with reduced side effects.

Applications in Molecular Probes: In addition to its role in drug development, N-(2-(2-Chloroethoxy)ethyl)-4-Formylbenzamide is being studied as a molecular probe for detecting and analyzing specific biomolecules. The formylbenzamide group provides a reactive site that can form covalent bonds with target proteins, offering a unique method for studying protein interactions and cellular pathways. This feature is particularly valuable in proteomics and drug screening assays, where understanding the binding affinity and specificity of potential drug candidates is critical. Its potential use as a probe in various biochemical assays demonstrates its versatility in the research field.

Contribution to Anti-cancer Research: The compound's structural elements suggest it may play a role in the inhibition of key signaling pathways involved in cancer cell growth. Studies have shown that formylbenzamide derivatives exhibit activity against certain types of cancer cells, with the chloroethoxy group potentially influencing the compound's ability to cross cellular membranes and interact with intracellular targets. This opens up possibilities for N-(2-(2-Chloroethoxy)ethyl)-4-Formylbenzamide to be explored as part of next-generation cancer therapeutics. Its selective activity could help in developing treatments that minimize damage to healthy tissues while targeting cancerous cells.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Zilovertamab vedotin | Boc-Val-Cit-PABA | 4-Formyl-N-(2-Phenoxyethyl)benzamide | Lycorine hydrochloride | Bis-PEG2-NHS Ester | N-(2-(2-Fluorophenoxy)ethyl)-4-Formylbenzamide | Fmoc-D-Val-D-Cit-PAB | Z-D-Dbu(N3)-OH | N-(2-(3-Fluorophenoxy)ethyl)-4-Formylbenzamide | N-(2-(4-Fluorophenoxy)ethyl)-4-Formylbenzamide | N-(2-(2-Chloroethoxy)ethyl)-4-Formylbenzamide
Send Inquiry
Verification code
Inquiry Basket